Bausch Health
334 hedge funds and large institutions have $3.54B invested in Bausch Health in 2018 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 96 increasing their positions, 109 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
334
Holders Change
+3
Holders Change %
+0.91%
% of All Funds
7.45%
Holding in Top 10
10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-16.67%
% of All Funds
0.22%
New
60
Increased
96
Reduced
109
Closed
54
Calls
$365M
Puts
$716M
Net Calls
-$351M
Net Calls Change
+$174M
Top Buyers
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$60.5M |
| 2 |
GCM
Glenview Capital Management
New York
|
+$56.5M |
| 3 |
O
OrbiMed
New York
|
+$31.3M |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
+$28.8M |
| 5 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
+$28.7M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$31.9M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$26.5M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$24.4M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$22.7M |
| 5 |
JPMorgan Chase & Co
New York
|
-$22.3M |
